Several pharmaceutical companies showcased data on their BTK inhibitors at the ASCO 2023 conference, including Ono ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial ...

Bristol Myers BMY recently announced that it will acquire privately held biotechnology company Orbital Therapeutics for $1.5 ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to UB-VV111 for the treatment of ...

At a memorial service in 2022, veteran Air Force Capt. Monte Watts bumped into a fellow former Minuteman III nuclear missile ...

AstraZeneca's deal follows a similar agreement Pfizer announced late last month. Advocates have generally praised the ...

Researchers at Weill Cornell Medicine and the University of Adelaide have developed GoT-Multi, a tool that tracks multiple ...

A novel tool created by researchers at Weill Cornell Medicine and the University of Adelaide has improved the capacity to ...

日本血液学会（JSH）第87届年会于2025年10月10日至12日在日本神户盛大召开。本次大会上，一项评估亚太地区套细胞淋巴瘤（MCL）患者接受二线或三线BTK抑制剂序贯治疗的疗效研究数据得以公布。哈尔滨血液病肿瘤研究所马军教授亲赴JSH现场，第一时 ...

Blood Cancer United, which was formerly known as the Leukemia & Lymphoma Society, has created a way for blood cancer patients ...

Halozyme Therapeutics stock is a solid choice to leverage the current momentum. It offers strong margins, low-debt capital ...

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today ...